CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRVO CervoMed

Market Closed 05-15 16:00:00 EDT

3.44

-0.32

-8.51%

盘后3.40

-0.04-1.16%

19:45 EDT

High3.74	Low3.35	Vol119.64K
Open3.74	D1 Closing3.76	Amplitude10.37%
Mkt Cap31.83M	Tradable Cap16.97M	Total Shares9.25M
T/O421.66K	T/O Rate2.42%	Tradable Shares4.93M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":3.44,"timestamp":1778875200000,"preClose":3.76,"halted":0,"volume":119643,"hourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.44,"latestTime":"19:45 EDT","volume":1008,"amount":3427.6239,"timestamp":1778888706358,"change":-0.04,"changeRate":-0.011628,"amplitude":0.011628},"delay":0,"changeRate":-0.08510638297872336,"floatShares":4934300,"shares":9252719,"eps":-2.982424,"marketStatus":"Market Closed","change":-0.32,"latestTime":"05-15 16:00:00 EDT","open":3.74,"high":3.74,"low":3.35,"amount":421658.542758,"amplitude":0.103723,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.982424,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.76,"preHourTrading":{"tag":"盘前","latestPrice":3.68,"preClose":3.76,"latestTime":"09:28 EDT","volume":51,"amount":191.66999520000002,"timestamp":1778851735687,"change":-0.08,"changeRate":-0.021277,"amplitude":0.021277},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.44,"latestTime":"19:45 EDT","volume":1008,"amount":3427.6239,"timestamp":1778888706358,"change":-0.04,"changeRate":-0.011628,"amplitude":0.011628},"volumeRatio":3.082411974278548},"requestUrl":"/m/hq/s/CRVO","defaultTab":"news","newsList":[{"id":"2635554770","title":"CervoMed Q1 EPS $(0.86) Misses $(0.78) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635554770","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635554770?lang=en_us&edition=fundamental","pubTime":"2026-05-16 07:02","pubTimestamp":1778886147,"startTime":"0","endTime":"0","summary":"CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.78) by 10.26 percent. This is a 53.57 percent decrease over losses of $(0.56) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620735/cervomed-q1-eps-0-86-misses-0-78-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CervoMed Q1 EPS $(0.86) Misses $(0.78) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635030050","title":"Top News Today: Stocks Slide, Treasury Yields Rise on Strait, Inflation Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2635030050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635030050?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:42","pubTimestamp":1778877720,"startTime":"0","endTime":"0","summary":"TREASURYS: Treasury yields rose amid fears the energy shock caused by the Iran war would trigger another global wave of inflation.COMMODITIES: Oil futures rose 4.2% in New York, topping $105 a barrel, amid fears that global reserves that have cushioned the blow of the strait's closure would soon reach critical lows.Trump and Xi Want to Stabilize U.S.-China Ties. Now Comes the Hard Part.SpaceX is aiming to go public on June 12, according to people familiar with the matter, setting the stage for what is expected to be the biggest initial public offering of all time.Anthropic is raising more than $30 billion at a $900 billion valuation as the AI giant seeks funding ahead of its widely expected initial public offering, according to people familiar with the matter.Starbucks is laying off 300 U.S. workers and closing several regional corporate offices in the latest move by Chie","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0994945656.USD","AGYS","OMTK","LU0323240290.USD","GOSS","LU1235294995.USD","LU1564329032.USD","LU3102509885.SGD","MSFL","LYRA","LU1043141396.HKD","LU2097344431.USD","IGC","LU0158827781.USD","LU0302445910.USD","SIEB","MSFU","MSFO","LU1084165304.USD","LU1934455194.USD","IE00B7KXQ091.USD","LU1935042215.USD","MSFY","CRVO","LU1316542783.SGD","LU0109391861.USD","BRC","MSFD","LU2265009873.SGD","LU1564329115.USD","LU0528227936.USD","SG9999015945.SGD","LU0107464264.USD","LU0211327993.USD","LU0348723411.USD","ASPI","MSFT","MSFX","LU1003077747.HKD","BK4528","MSFW","SG9999015952.SGD","IE00B775SV38.USD","LU2506952097.USD","IE00BJTD4V19.USD","LU0965509101.SGD","IE00B3SWFQ91.USD","LU0006306889.USD","AWHL","LU0256863902.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635003698","title":"CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635003698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635003698?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:32","pubTimestamp":1778859140,"startTime":"0","endTime":"0","summary":"CervoMed Inc reports results for the quarter ended March 31 - Earnings SummaryCervoMed Inc CRVO.OQ reported a quarterly adjusted loss of 86 cents per share for the quarter ended March 31, lower than t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S1PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087113","title":"Cervomed Q1 FY26 net loss widens 63% to $7.96 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087113","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087113?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:12","pubTimestamp":1778850758,"startTime":"0","endTime":"0","summary":"Cervomed posted a net loss of $7.96 million for the three months ended March 31, 2026, widening 63% from a year earlier.Operating loss widened to $8.11 million, driven by no grant revenue versus $1.92 million a year earlier.Total operating expenses rose 12% to $8.11 million, with research and development up 6% to $5.14 million.General and administrative costs climbed 25% to $2.98 million, while interest income fell 64% to $147,387.Cash, cash equivalents, and marketable securities totaled about $12.9 million at March 31, 2026; management said this is not expected to fund operations for at least 12 months, and the company continues to plan a Phase 3 DLB trial subject to funding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3J6frX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088868","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635088868?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:00","pubTimestamp":1778839200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.,·H World ADR                                     1Q       .45       BMO. ,·RBC Bearings                                     4Q      3.33   8:00 AM. ,·Compugen Ltd.                                   1Q      (.07)  7:00 AM. ,·iQIYI ADR                                         1Q      (.03)  5:00 AM. ,·Modiv Ind Cl C                                   1Q       .01. ,·8x8 Inc.                                        4Q       .08   4:05 PM. ,·Amer Sports                                       1Q       .31   6:00 AM. ,·Bilibili Spon                                   1Q       .17   6:00 AM. ,·Canaan Spon ADR                                  1Q      (.03)      BMO. ,·CAVA Grp                                        1Q       .17   4:10 PM. ,·Ceragon Net                                     1Q       .01   7:00 AM. ,·Eagle Materials                     ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AS","ELF","CRNT","GCTS","BURL","BZ","DECK","GCO","INTU","AAP","FATN","CMBT","DE","HLNE","ECC","FLO","GDS","GLNG","IMVT","BULL","BLTE","BILI","BORR","IQ","HSAI","HAS","CRVO","DOMO","CAE","EGHT","AGYS","BIDU","CPRT","BNTC","BTM","EARN","CDLR","EDRY","CAN","ENS","CAVA","ADI","HD","BBW","BEKE","CGEN","ALMS","EXP","DAVA","HTHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634463078","title":"CervoMed Inc  expected to post a loss of 78 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634463078","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634463078?lang=en_us&edition=fundamental","pubTime":"2026-05-09 00:34","pubTimestamp":1778258046,"startTime":"0","endTime":"0","summary":"CervoMed Inc  expected to post a loss of78cents a share - Earnings Preview CervoMed Inc CRVO.OQ CRVO.O is expected to  show a fall in quarterly revenue when it reports  results on May 11 (estimated) f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L22K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631311656","title":"CervoMed announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2631311656","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631311656?lang=en_us&edition=fundamental","pubTime":"2026-04-30 22:23","pubTimestamp":1777558985,"startTime":"0","endTime":"0","summary":"CervoMed schedules 2026 annual stockholder meeting for June 8, 2026, to be held virtually via live webcast.Shareholders will vote to elect eight directors to serve until next annual meeting.Advisory vote planned on compensation for named executive officers for year ended Dec. 31, 2025.Proposal seeks approval of Amendment No. 1 to 2025 Equity Incentive Plan to increase authorized shares by 2 million to 2.8 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL5h2BLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629811899","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cochlear (OtherCHEOF), CervoMed (CRVO) and Community Health (CYH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629811899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629811899?lang=en_us&edition=fundamental","pubTime":"2026-04-24 17:01","pubTimestamp":1777021314,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cochlear (CHEOF), CervoMed (CRVO) and Community Health (CYH). Coc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cochlear-othercheof-cervomed-crvo-and-community-health-cyh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cochlear-othercheof-cervomed-crvo-and-community-health-cyh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XBI","LU0029874061.USD","BK4082","CHEOF","BK4139","BK4185","BK4588","LU0128526141.USD","XLV","LABU","BK4137","BK4585","CRVO","CYH","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629395638","title":"CervoMed Price Target Maintained With a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629395638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629395638?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:02","pubTimestamp":1776945720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRVO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 23, 2026 08:02 ET (12:02 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629783552","title":"Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed","url":"https://stock-news.laohu8.com/highlight/detail?id=2629783552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629783552?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:15","pubTimestamp":1776942956,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on CRVO stock, giving a Buy rating on April 14. Ram Selvaraju has given h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/neflamapimods-mri-and-connectivity-data-support-disease‑modifying-potential-in-dementia-with-lewy-bodies-and-underscore-buy-rating-on-cervomed-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/neflamapimods-mri-and-connectivity-data-support-disease‑modifying-potential-in-dementia-with-lewy-bodies-and-underscore-buy-rating-on-cervomed-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629407190","title":"CervoMed presents neflamapimod MRI data","url":"https://stock-news.laohu8.com/highlight/detail?id=2629407190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629407190?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:32","pubTimestamp":1776868379,"startTime":"0","endTime":"0","summary":"CervoMed (CRVO) presented placebo-controlled magnetic resonance imaging analyses providing evidence that neflamapimod may increase the size and enh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-presents-neflamapimod-mri-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-presents-neflamapimod-mri-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629043678","title":"CervoMed says neflamapimod boosts right basal forebrain volume in Lewy body dementia trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629043678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629043678?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:30","pubTimestamp":1776857434,"startTime":"0","endTime":"0","summary":"CervoMed presented new placebo-controlled MRI analyses at 2026 AAN Annual Meeting showing neflamapimod improved brain structure and function tied to dementia with Lewy bodies.Results indicated treatment increased basal forebrain volume versus decline on placebo, supporting a potential disease-modifying effect rather than symptomatic benefit.Extension-period imaging also showed stronger functional connectivity in relevant brain networks, aligning with clinical improvement trends reported from trial follow-up.CervoMed plans to incorporate MRI measures into a Phase 3 DLB trial targeted to start later in 2026, subject to financing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL5v1j9z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014005.SGD","NDAQ","BK4112","BK4139","CRVO","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4585","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627982422","title":"Roth MKM Remains a Buy on CervoMed (CRVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627982422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627982422?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:17","pubTimestamp":1776201435,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on CervoMed, with a price target of $11.00. Pachaiyappan co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625553949","title":"CervoMed Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2625553949","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625553949?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:19","pubTimestamp":1775650740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRVO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2026 08:19 ET (12:19 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625969377","title":"CervoMed Highlights Neflamapimod Progress in Lewy Body Dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2625969377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625969377?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:50","pubTimestamp":1775595044,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) just unveiled an announcement. On April 7, 2026, CervoMed announced that its representatives would present key aspects of the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-neflamapimod-progress-in-lewy-body-dementia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-neflamapimod-progress-in-lewy-body-dementia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4139","PRGS","BK4097","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930187","title":"CervoMed says new Phase 2b MRI analysis supports neflamapimod slowing DLB progression","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930187","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930187?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:06","pubTimestamp":1775563602,"startTime":"0","endTime":"0","summary":"CervoMed outlined updated plans for neflamapimod development in dementia with Lewy bodies at 2026 Lewy Body Dementia Association Annual Meeting.Update included new MRI analyses from Phase 2b RewinD-LB trial that suggest treatment could slow brain changes linked to cognitive decline.Company also highlighted biomarker work indicating blood marker signals tracked with clinical outcomes during neflamapimod treatment.CervoMed said it has completed Phase 3 trial design and reached alignment with global regulators on planned study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL2rfbRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601708","title":"CervoMed (CRVO) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625601708?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:38","pubTimestamp":1775507914,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy maintained a Buy rating on CervoMed today and set a price target of $20.00. According to TipRanks, Roy is an analys...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cervomed-crvo-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cervomed-crvo-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084075","title":"CervoMed Posts Investor Presentation Under Regulation FD Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084075?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:38","pubTimestamp":1774298305,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has provided an announcement. CervoMed Inc. has posted an investor presentation on its website under the Investors – Events an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-posts-investor-presentation-under-regulation-fd-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-posts-investor-presentation-under-regulation-fd-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621008125","title":"Cervomed Inc. Publishes Presentation Factsheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2621008125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621008125?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:08","pubTimestamp":1774296504,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL6qDlWT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620717832","title":"CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620717832","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620717832?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:59","pubTimestamp":1773953977,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has shared an update. On March 19, 2026, CervoMed reported new analyses from its Phase 2b RewinD-LB trial showing that DLB pat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-rewind-lb-phase-2b-biomarker-driven-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-highlights-rewind-lb-phase-2b-biomarker-driven-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO","BK4233","BK4213","BK4139","LB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":-0.1291},{"period":"1month","weight":-0.1485},{"period":"3month","weight":-0.2712},{"period":"6month","weight":-0.5521},{"period":"1year","weight":-0.6019},{"period":"ytd","weight":-0.5646}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.023389},{"month":2,"riseRate":0.5,"avgChangeRate":0.085839},{"month":3,"riseRate":0.5,"avgChangeRate":0.326048},{"month":4,"riseRate":0.3,"avgChangeRate":-0.063988},{"month":5,"riseRate":0.4,"avgChangeRate":0.125202},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.121539},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.07795},{"month":8,"riseRate":0.666667,"avgChangeRate":0.076308},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.117703},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.039339},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.045938},{"month":12,"riseRate":0.3,"avgChangeRate":-0.206034}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CervoMed(CRVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CervoMed(CRVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction